How to choose initial treatment in multiple sclerosis patients: a case-based approach.

Samira Luísa Apóstolos Pereira Mateus Boaventura Natalia Trombini Mendes Larissa Silva Teixeira Igor Gusmão Campana

Published in: Arquivos de neuro-psiquiatria (2022)

Advances in MS treatment are remarkable. Strong evidence supports the use of early high efficacy therapy. However, biomarkers, clinical and radiologic prognostic factors, as well as patients' individual issues, should be valued and considered for a personalized treatment decision.

Keyphrases

prognostic factors
multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
stem cells
mesenchymal stem cells
cell therapy